Drug Shortage Report for SANDOZ BRIMONIDINE
Report ID | 41626 |
Drug Identification Number | 02305429 |
Brand name | SANDOZ BRIMONIDINE |
Common or Proper name | BRIMONIDINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.2% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-03-05 |
Actual start date | 2018-03-16 |
Estimated end date | 2018-05-18 |
Actual end date | 2018-05-04 |
Shortage status | Resolved |
Updated date | 2018-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-02 | English | Compare |
v2 | 2018-03-02 | French | Compare |
v3 | 2018-03-06 | English | Compare |
v4 | 2018-03-27 | English | Compare |
v5 | 2018-03-27 | French | Compare |
v6 | 2018-05-23 | English | Compare |
v7 | 2018-05-23 | French | Compare |
Showing 1 to 7 of 7